Sensor Technology Assessments of Reproductive Target Study
NCT06142097 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 119
Last updated 2024-10-15
Summary
The objective of this study was to better understand female reproductive health in the context of using wearable technology. Participants were provided and wore an Oura Ring, tracked their menstrual cycles, provided at-home ovulation test results, and had their cycles monitored via trans-vaginal ultrasounds. The study aimed to collect data from females with regular menstrual cycles.
Conditions
- Menstrual Cycle
- Ovulation
- Menstruation
Sponsors & Collaborators
-
UCSF Center for Reproductive Health
collaborator UNKNOWN -
Ouraring Inc.
lead INDUSTRY
Principal Investigators
-
Eleni Jaswa, M.D., M.Sc. · UCSF Center for Reproductive Health
Eligibility
- Min Age
- 18 Years
- Max Age
- 42 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-15
- Primary Completion
- 2024-09-30
- Completion
- 2024-09-30
Countries
- United States
Study Locations
More Related Trials
-
Effects of Gynecological Age on LH Sensitivity to Energy Availability
NCT00260286 ·Status: COMPLETED ·Phase: NA
-
Performance During Menstrual Cycle
NCT03832972 ·Status: COMPLETED
-
Clinical Safety Study of the Progesterone Vaginal Ring in Women Undergoing Assisted Reproductive Technology Procedures
NCT03565211 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of The Cycle SyncingⓇ Method: A 12-Week Virtual Clinical Trial
NCT07286136 ·Status: COMPLETED ·Phase: NA
-
Oral Contraceptive Pills Compared to Vaginal Rings
NCT00357526 ·Status: COMPLETED ·Phase: NA
-
PARIS or PAtch RIng Study: A Trial to Evaluate NuvaRing Versus OrthoEvra
NCT00269620 ·Status: COMPLETED ·Phase: PHASE4
-
AROPE : Early Ovarian Reserve Decreased : Impact of Exposure to Persistent Endocrine Disruptors and Organic Solvents
NCT02802397 ·Status: COMPLETED ·Phase: NA
-
Effect of Oestrogen on Musculoskeletal Outcomes
NCT05587920 ·Status: UNKNOWN
-
Continuous Use of the Contraceptive Patch and the Personal Economic Impact.
NCT00357981 ·Status: WITHDRAWN ·Phase: NA
-
The Effect of Menstrual Cycle and Oral Contraceptive Pill Phase on Aspects of Exercise Physiology
NCT05683119 ·Status: RECRUITING ·Phase: NA
-
Performance and Safety of Vaginal Ring Applicator in Healthy Females (MK-8342A-063)
NCT02275546 ·Status: COMPLETED ·Phase: PHASE3
-
Combined Hormonal Contraceptive Use in High Risk Women: A Longitudinal Study
NCT00361400 ·Status: COMPLETED
-
Quantum Menstrual Health Monitoring Study
NCT05936840 ·Status: RECRUITING
-
The Copper T380A IUD vs. Oral Levonorgestrel for Emergency Contraception
NCT00966771 ·Status: COMPLETED
-
Immediate Postpartum Insertion of Contraceptive Intrauterine Devices
NCT03657602 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Tracking IUD Bleeding Experiences: An Evaluation of Bleeding Profiles in New Intrauterine Device Users
NCT02311478 ·Status: COMPLETED ·Phase: NA
-
Study of the Use of a Contraceptive Vaginal Ring (NuvaRing) in Normal Daily Practice in Indian Women (P07733)
NCT01490190 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Oral Contraception Under Simulated OTC Conditions
NCT03559010 ·Status: TERMINATED ·Phase: PHASE3
-
Quick Start of Highly Effective Contraception
NCT02076217 ·Status: COMPLETED
-
Hormonal Contraception and Vaginal Health
NCT00612508 ·Status: COMPLETED ·Phase: NA
-
Assessing Ovarian Function During Prolonged Implant Use
NCT03058978 ·Status: COMPLETED
-
Stopping Heavy Periods Project
NCT02002260 ·Status: UNKNOWN ·Phase: NA
-
Assessing the Endometrial Environment in Recurrent Pregnancy Loss and Unexplained Infertility
NCT03401918 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Efficacy, Safety, and Tolerability of LevoCept
NCT04457076 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
The Effect of an Adhesive Overlay on the Delivery of Contraceptive Hormones From ORTHO EVRA® in Healthy Women
NCT01535820 ·Status: COMPLETED ·Phase: PHASE1